Vir Biotechnology, Inc. reports

Location: San Francisco, CA
Fiscal year end: 31 December

Vir Biotechnology, Inc. has filed 771 SEC EDGAR filings since 29 Jun 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 426-450 of 771 matching filings.

Per page

25

Current page

18

5

FORM 5 SUBMISSION

Filing date: 14 Feb 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91177

SC 13G/A

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91177

SEC SCHEDULE 13G

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91177

AMENDMENT TO FORM SC 13G

Filing date: 10 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91177

SCHEDULE 13G

Filing date: 10 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Feb 2022
Reporting date: 08 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Feb 2022
Reporting date: 02 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 26 Jan 2022
Reporting date: 25 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Jan 2022
Reporting date: 19 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Jan 2022
Reporting date: 18 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Jan 2022
Reporting date: 11 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-91177

ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#4)

Filing date: 10 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 06 Jan 2022
Reporting date: 05 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Dec 2021
Reporting date: 28 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 22 Dec 2021
Reporting date: 20 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 22 Dec 2021
Reporting date: 20 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 Dec 2021
Reporting date: 20 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39083

8-K

Filing date: 22 Dec 2021
Reporting date: 16 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Dec 2021
Reporting date: 20 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Dec 2021
Reporting date: 15 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Dec 2021
Reporting date: 14 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Dec 2021
Reporting date: 01 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Dec 2021
Reporting date: 30 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Dec 2021
Reporting date: 30 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Dec 2021
Reporting date: 30 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .